Date: 2025/05/15 - 19:00
Three months of 8-hour time-restricted eating (TRE), regardless of the time of the day, helped sustain long-term weight loss in adults with overweight or obesity, preliminary results from a clinical trial has shown.
Date: 2025/05/13 - 23:32
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.
Date: 2025/05/12 - 22:00
A 3-month time-restricted eating (TRE) protocol resulted in up to one year of sustained weight loss in people with overweight or obesity. Adhering to an 8-hour window of eating led to greater weight loss than eating throughout the day, whether early or late.
Date: 2025/05/11 - 19:00
Michelle and Samantha Pearson are a mother-daughter duo diagnosed with NF1-PN, a rare and painful disease that causes benign tumor growth along nerves throughout the body. After living with NF1-PN for four years, Samatha was accepted into a clinical trial that changed her life.